Genome-wide methylation analysis of bladder cancer tissues discovered hypermethylation in the promoter region of a number of genes; with the combined hypermethylation of SOX1, PITX2, or versican identifying patients with a higher risk of bladder cancer morbidity (59). Here, PITX2 is linked to urinary bladder cancer.